SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs informs about closure of trading window

22 Dec 2025 Evaluate

Pursuant to Company’s Code Prohibition of Insider Trading framed pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments thereunder, Aarti Pharmalabs has informed that the trading window for dealing in the securities of the Company will remain closed from Thursday, January 01, 2026 till 48 hours after the declaration of Financial Results of the Company for the quarter ending December 31, 2025. The same has also been intimated to all the Designated Persons/Connected Persons of the Company. The date of the Board Meeting in which the said results will be considered for approval, will be informed in due course.

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

701.00 1.55 (0.22%)
17-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1239.00
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2321.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×